Chengdu Zenitar Biomedical Technology Co., Ltd

This was a first-in-human study to test the safety and find the right dose of a new drug called Purinostat mesylate (PM). It involved 29 adults with advanced blood cancers, like lymphoma and leukemia, that had returned or stopped responding to standard treatments. The main goal w…

This early-stage study tested a new oral drug called flonoltinib in adults with myeloproliferative neoplasms (MPNs), a group of rare bone marrow cancers. The main goals were to check the drug's safety, find the highest tolerable dose, and see how the body processes it. Researcher…

This was an early-stage study to test the safety of a new, unapproved drug called ZL-82 in healthy people. Researchers gave 41 volunteers single and multiple doses of the pill or a placebo to see how their bodies handled it, checking for side effects and measuring the drug's leve…

This early-stage study aimed to understand if eating a high-fat meal changes how the body absorbs and processes a single dose of a new drug called flonoltinib. It involved 24 healthy volunteers who took the pill both on an empty stomach and after a meal. The main goal was to meas…

This was a first-in-human study to check the safety and how the body processes a new drug called flonoltinib maleate. It involved 40 healthy adult volunteers in China who received either a single dose of the drug or a placebo. The main goal was to see how safe the drug was and to…